Clinical Trial Update: Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety and potential efficacy of PEEL-224 in combination with vincristine and temozolomide in adolescents and young…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoplastic Small Round Cell Tumor
• Ewing Sarcoma
• Osteosarcoma
• Rhabdomyosarcoma
• Sarcoma

Drugs mentioned

• PEEL-224
• Temozolomide (Temozolomide)
• Vincristine (vincristine)

Snippet

Sponsor: David S Shulman, MD | Conditions: Sarcoma, Sarcoma, Ewing | Phase 1, Phase 2 | Status: RECRUITING